RMR Wealth Builders boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 4.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,699 shares of the medical equipment provider’s stock after purchasing an additional 236 shares during the quarter. RMR Wealth Builders’ holdings in Intuitive Surgical were worth $2,975,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the stock. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical in the 2nd quarter worth approximately $37,000. Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $38,000. Finally, DT Investment Partners LLC grew its holdings in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Intuitive Surgical Price Performance
Intuitive Surgical stock traded up $3.45 during trading hours on Friday, hitting $547.47. 1,732,022 shares of the stock traded hands, compared to its average volume of 1,340,430. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $556.23. The firm’s 50 day moving average price is $535.11 and its 200-day moving average price is $493.61. The stock has a market capitalization of $195.00 billion, a price-to-earnings ratio of 88.02, a P/E/G ratio of 5.31 and a beta of 1.39.
Analyst Upgrades and Downgrades
ISRG has been the subject of several research reports. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $554.17.
Read Our Latest Analysis on Intuitive Surgical
Insider Transactions at Intuitive Surgical
In other news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Energy and Oil Stocks Explained
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Evaluate a Stock Before Buying
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.